Posted by Michael Wonder on 03 Feb 2021
Parkinson’s disease drug Equifina gets insurance benefits
1 February 2021 - The government has decided to grant health insurance benefits to Eisai’s Parkinson’s disease treatment, Equifina (safinamide), and Santen’s eye drop, Eybelis, (omidenepag isopropyl) from February.
It also expanded the reimbursement scope for Takeda’s ovarian cancer drug, Zejula.
